Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DYGN - Dynagen -- Ignore unavailable to you. Want to Upgrade?

To: Katie Kommando who wrote (418)	7/14/1999 1:10:00 PM
From: Tadsamillionaire	Read Replies (1) \| Respond to of 444

Here is the info you requested. Robert Cusick was the president of International Murex Technologies.Under his direction annual sales grew from $250,000. to over $110 million. Warner Lambert chose Dynagen to manufacture their drug Pyridium in 1998. Dynagen has entered into an agreement with MOVA Labs to manufacture and distribute ZOTRIM. DYGN has numerous product under development and at various stages of completion. Additional products are expected to be launched in 1999 and considerably more in 2000. DYGN has an excellent client base which includes generic manufacture for Eckerd and Walgreen drug stores. SEE...... st4.yahoo.com Ragingbull.com Dynagen board. Please do your Due Diligence prior to investing in any stock. JMHO I am Long on DYGN